Home/ Supplements/ Lutein/ Sight Smart (Multivitamin + Lutein)

Sight Smart (Multivitamin + Lutein)

product on market Tablet or Pill Douglas Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 76% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile contains vitamins A, C, D3, E, and thiamine, which are supported by strong evidence for maintaining general ocular and systemic health. These nutrients act as antioxidants and essential cofactors to support cellular function. The evidence coverage for this specific combination is limited, though the individual components have well-established safety profiles.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Sight Smart (Multivitamin + Lutein)
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
76%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
2000 IU (40% DV)
Vitamin C
150 mg (250% DV)
800 IU (200% DV)
1.3× RDA — within safe limits 608 studies (A:16, B:251)
200 IU (667% DV)
8.9× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
1.5 mg (100% DV)
1.2× RDA — within safe limits 76 studies (A:0, B:33)
2 mg (118% DV)
1.5× RDA — within safe limits 13 studies (A:0, B:1)
20 mg (100% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
10 mg (500% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
400 mcg (100% DV)
Within RDA (1.0× RDA) 226 studies (A:10, B:105)
400 mcg (6667% DV)
166.7× RDA — above typical dose 139 studies (A:1, B:44)
10 mg (100% DV)
2.0× RDA — within safe limits 2 studies — no high-quality reviews
Calcium
100 mg (10% DV)
100 mg (25% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
100 mcg (143% DV)
1.8× RDA — within safe limits 173 studies (A:0, B:67)
100 mcg (83% DV)
2.9× RDA — within safe limits 199 studies (A:1, B:55)
3 mg
Market median: 10.0mg (105 products) 2 studies (A:0, B:1)

Other Ingredients

Cellulose Croscarmellose Sodium Vegetable Stearate Silica Pharmaceutical Glaze
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Usage: As a dietary supplement take 1 tablet daily with a meal, or as directed by your healthcare professional.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Tamper resistant package, do not use if outer seal is missing.

Formulation Notes

This product contains NO yeast, wheat gluten, soy protein, milk/dairy, corn, starch, artificial coloring, preservatives or flavoring.

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)

Formula #99818-30AO

Metadata

Product Details

UPC / SKU3 10539 02791 2
DSLD Entry Date2012-07-25
Product TypeOther Combinations
FormTablet or Pill
DSLD ID10511
Data Updated2026-04-11
Research

Research Evidence

8
Research Sources
46
Avg Quality
4
Rct
2
Clinical Trial
1
Systematic Review
B Systematic review of carotenoid concentrations in human milk and infant blood
Systematic Review Nutrition reviews 2022 PubMed DOI
C No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18
Rct Ophthalmology 2019 PubMed DOI
C Consumption of Hen Eggs Enriched with n-3 Polyunsaturated Fatty Acids, Selenium, Vitamin E and Lutein Incites Anti-Inflammatory Conditions in Young, Healthy Participants - A Randomized Study.
Rct Frontiers in bioscience (Landmark edition) PubMed DOI
C Effect of Dietary Supplementation with Lutein, Zeaxanthin, and Elderberries on Dry Eye Disease (DED) and Immunity: A Randomized Controlled Trial.
Rct Nutrients PubMed DOI
C Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration.
Rct Ophthalmology PubMed DOI
C The Influence of Lutein Supplements on Age-related Macular Degeneration
Clinical Trial ClinicalTrials.gov 2007
D Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60
Clinical Trial ClinicalTrials.gov 2005
D Lutein
View all evidence for Lutein →
Compare

Similar Products

View all Lutein products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.